Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort

RD Moore - JAIDS Journal of Acquired Immune Deficiency …, 1998 - journals.lww.com
The Johns Hopkins AIDS Service is the principal provider of medical care for HIV-infected
patients in Maryland, a state in which the majority of HIV-infected patients live in an urban …

Estimating the national cost of treating people with HIV disease: patient, payer, and provider data

FJ Hellinger, JA Fleishman - JAIDS Journal of Acquired Immune …, 2000 - journals.lww.com
Objective: Existing estimates of the national cost of treating all people with HIV disease use
data from a sample of people with HIV disease to extrapolate the cost of treating all people …

The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences

AB Hutchinson, PG Farnham, HD Dean… - JAIDS Journal of …, 2006 - journals.lww.com
Background: Assessing the economic burden of HIV/AIDS can help to quantify the effect of
the epidemic on a population and assist policy makers in allocating public health resources …

Contemporary costs of HIV healthcare in the HAART era

KA Gebo, JA Fleishman, R Conviser, J Hellinger… - Aids, 2010 - journals.lww.com
Background: The delivery of HIV healthcare historically has been expensive. The most
recent national data regarding HIV healthcare costs were from 1996–1998. We provide …

Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols

CB Gable, JC Tierce, D Simison, D Ward… - JAIDS Journal of …, 1996 - journals.lww.com
We report treatment protocols for HIV+/AIDS patients by CD4+ counts (T-lymphocyte
cells/mm 3:≥ 500, 499-200, 199-50, and< 50) as a tool to provide better definition and to …

Long-term impact of highly active antiretroviral therapy on HIV-related health care costs

P Keiser, N Nassar, MB Kvanli, D Turner… - JAIDS Journal of …, 2001 - journals.lww.com
Context: Highly active antiretroviral therapy (HAART) is associated with decreased
opportunistic infections, hospitalization, and HIV-related health care costs over relatively …

Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care

PG Farnham, C Gopalappa, SL Sansom… - JAIDS Journal of …, 2013 - journals.lww.com
Background: Lifetime costs of care and quality-of-life estimates for HIV-infected persons
depend on the disease stage at which these persons are diagnosed, enter care, and start …

The costs of AIDS in Los Angeles

CL Bennett, M Cvitanic, A Pascal - JAIDS Journal of Acquired …, 1991 - journals.lww.com
This article reports on the findings of a study of medical and non-medical expenditures of
persons with acquired immune deficiency syndrome (AIDS) in Los Angeles in 1987 and …

The changing direct costs of medical care for patients with HIV/AIDS, 1995–2001

HB Krentz, MC Auld, MJ Gill - CMAJ, 2003 - Can Med Assoc
Background: Determining the direct cost of providing medical care to patients with HIV/AIDS
is important for both short-term and long-term decision-making and for appropriate resource …

Costs of HIV medical care in the era of highly active antiretroviral therapy

KA Gebo, RE Chaisson, JG Folkemer, JG Bartlett… - Aids, 1999 - journals.lww.com
Objectives: In the USA, Medicaid is the principal payer of the health care costs of patients
with HIV infection. We wished to determine how the costs to Medicaid of patients in Maryland …